alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           3,637
<SECURITIES>                                         0
<RECEIVABLES>                                   54,613
<ALLOWANCES>                                     1,710
<INVENTORY>                                          0
<CURRENT-ASSETS>                                82,197
<PP&E>                                         134,050
<DEPRECIATION>                                   6,532
<TOTAL-ASSETS>                                 502,812
<CURRENT-LIABILITIES>                           54,727
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           330
<OTHER-SE>                                    (14,634)
<TOTAL-LIABILITY-AND-EQUITY>                   502,812
<SALES>                                              0
<TOTAL-REVENUES>                               139,096
<CGS>                                                0
<TOTAL-COSTS>                                  118,024
<OTHER-EXPENSES>                                 (113)
<LOSS-PROVISION>                                   582
<INTEREST-EXPENSE>                              16,716
<INCOME-PRETAX>                                 21,185
<INCOME-TAX>                                     8,162
<INCOME-CONTINUING>                             13,023
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                (1,373)
<CHANGES>                                            0
<NET-INCOME>                                    11,650
<EPS-BASIC>                                       0.37
<EPS-DILUTED>                                     0.36


</TABLE>
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, April 27, 2017.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, April 27, 2017

The Court of Appeals hereby passes the following order

A17D0372. W.K. BISHOP v. LYNN MARIE HARRISON.

Upon consideration of the Application for Discretionary Appeal, it is ordered that it be 

hereby DENIED.

LC NUMBERS:

2015CV258539
### -82 -80 -78 -76 -74

38 40 42



## ★ ▲ ▲ ▲ ▲



## ★ ▲ ▲ ▲ ▲ 

### 500 1000 1500 100 18 12 06 00 06/21 

## NOAA HYSPLIT MODEL 

# Backward trajectory ending at 2300 UTC 21 Jun 06

EDAS Meteorological DataSource★at 38.90 N 76.65 WMeters AGL 

## ★ ■ ■ ■ ■



## ★ ■ ■ ■ ■ 

## ★ ● ● ● ●



## ★ ● ● ● ●
FILED IN 4th COURT OF APPEALS SAN ANTONIO, TEXAS 3/31/2015 10:24:13 AM KEITH E. HOTTLE Clerk
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2450 Supplement for culture media. ( a ) *Identification.* A supplement for culture media is a device, such as a vitamin or sugar mixture, that is added to a solid or liquid basal culture medium to produce a desired formulation and that is intended for medical purposes to enhance the growth of fastidious microorganisms (those having complex nutritional requirements). This device aids in the diagnosis of diseases caused by pathogenic microorganisms.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 54 FR 25046, June 12, 1989; 66 FR 38791, July 25, 2001]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.7100 Red blood cell enzyme assay. ( a ) *Identification.* Red blood cell enzyme assay is a device used to measure the activity in red blood cells of clinically important enzymatic reactions and their products, such as pyruvate kinase or 2,3-diphosphoglycerate. A red blood cell enzyme assay is used to determine the enzyme defects responsible for a patient's hereditary hemolytic anemia.
( b ) *Classification.* Class II (performance standards).
[45 FR 60610, Sept. 12, 1980]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.7500 Whole blood hemoglobin assays. ( a ) *Identification.* A whole blood hemoglobin assay is a device consisting or reagents, calibrators, controls, or photometric or spectrophotometric instrumentation used to measure the hemoglobin content of whole blood for the detection of anemia. This generic device category does not include automated hemoglobin systems.
( b ) *Classification.* Class II (special controls). An acid hematin intended for use with whole blood hemoglobin assays is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
[45 FR 60622, Sept. 12, 1980, as amended at 84 FR 71799, Dec. 30, 2019]
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1415 Iron-binding capacity test system. ( a ) *Identification.* An iron-binding capacity test system is a device intended to measure iron-binding capacity in serum. Iron-binding capacity measurements are used in the diagnosis and treatment of anemia.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
[52 FR 16122, May 1, 1987, as amended at 84 FR 71796, Dec. 30, 2019]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. ID-3716-001]

Take notice that on February 12, 2010, David C. Ellsworth filed an informational report for authority to hold interlocking positions, pursuant to section 45.9 of the Commission's Regulations, 18 CFR 45.9 (2009).

Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211, 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed on or before the comment date. Anyone filing a motion to intervene or protest must serve a copy of that document on the Applicant and all the parties in this proceeding.

                    The Commission encourages electronic submission of protests and interventions in lieu of paper using the “eFiling” link at                     *http://www.ferc.gov*. Persons unable to file electronically should submit an original and 14 copies of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426.                

                    This filing is accessible on-line at                     *http://www.ferc.gov*, using the “eLibrary” link and is available for review in the Commission's Public Reference Room in Washington, DC. There is an “eSubscription” link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail                     *FERCOnlineSupport@ferc.gov*, or call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.                

*Comment Date:*                     5 p.m. Eastern Time on March 5, 2010.                

Kimberly D. Bose,

Secretary. 

[FR Doc. 2010-4611 Filed 3-4-10; 8:45 am]

BILLING CODE 6717-01-P
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 01-40437 Conference Calendar
UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus
ABRAHAM GARCIA-AGUILERA, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Southern District of Texas USDC No. C-00-CR-350-1

-------------------- December 12, 2001 Before HIGGINBOTHAM, BARKSDALE, and STEWART, Circuit Judges. PER CURIAM: * The Federal Public Defender appointed to represent Abraham Garcia-Aguilera has moved for leave to withdraw and has filed a brief as required by Anders v. California , 386 U.S. 738 (1967). Garcia-Aguilera has received a copy of counsel’s brief and motion but has not filed a response. Our independent review of counsel’s Anders brief and the record discloses no nonfrivolous issue for appeal. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. 5 TH C IR . R. 42.2.
##### 



Exhibit 99.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Capital Pacific Holdings, Inc. (the
Company) on Form 10-Q for the period ending May 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Steven
O. Spelman, Jr., Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. § 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) |  | The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and                              
| | --- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (2) |  | The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of
the Company.

| |  |     |  |                                                
| |  | --- |  | -----------------------------------------------
| |  | By: |  | /s/ Steven O. Spelman, Jr.                     
| |  |     |  |                                                
| |  |     |  | Steven O. Spelman, Jr.                         
| |  |     |  | Chief Financial Officer and Corporate Secretary
| |  |     |  | (Principal Financial Officer)                  

Date: July 15, 2003
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3250 Cocaine and cocaine metabolite test system. ( a ) *Identification.* A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.
( b ) *Classification.* Class II (special controls). A cocaine and cocaine metabolite test system is not exempt if it is intended for any use other than employment or insurance testing or is intended for Federal drug testing programs. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing, and does not include devices intended for Federal drug testing programs (*e.g.,* programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military).
[52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019]
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 _________________________________________

 Clerk

December 5, 2012

h1128

Order 

December 5, 2012

144316 & (55)

_______________________________________

In Re Conservatorship of DEANNA

THERESA CISNEROS.

_______________________________________

MARK A. FULLMER, Successor Conservator

of DEANNA THERESA CISNEROS, a 

Protected Person,

Petitioner-Appellee,

v SC: 144316

COA: 298922

St. Clair Probate Court:

AUTO CLUB INSURANCE ASSOCIATION, 07-110072-CA

Respondent-Appellant.

_______________________________________/

On order of the Court, the motion for leave to file statement of supplemental 

authority is GRANTED. By order of April 18, 2012, the application for leave to appeal 

the September 27, 2011 judgment of the Court of Appeals was held in abeyance pending 

the decisions in Johnson v Recca (Docket No. 143088) and Douglas v Allstate Ins Co

(Docket No. 143503). The cases having been decided on July 30, 2012, 492 Mich 169 

(2012), and 492 Mich 241 (2012), the application is again considered and, pursuant to 

MCR 7.302(H)(1), in lieu of granting leave to appeal, we VACATE the judgment of the 

Court of Appeals and REMAND this case to the Court of Appeals for reconsideration in 

light of our decisions in Johnson and Douglas.
# C_2015205EN.01004203.xml

| 22.6.2015 | EN | Official Journal of the European Union | C 205/42 |
| --- | --- | --- | --- |

22.6.2015

EN

Official Journal of the European Union

C 205/42

---

Order of the General Court of 13 April 2015 — noon Copenhagen v OHIM — Wurster Diamonds (noon)

(Case T-637/14) (1)

1

(2015/C 205/58)

Language of the case: English

The President of the Fifth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 361, 13.10.2014.

1

---
[Federal Register Volume 75, Number 42 (Thursday, March 4, 2010)]
[Notices]
[Page 10017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4626]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY


Submission for OMB Review; Comment Request

March 1, 2010.
    The Department of the Treasury will submit the following public 
information collection requirement(s) to OMB for review and clearance 
under the Paperwork Reduction Act of 1995, Public Law 104-13, on or 
after the publication date of this notice. Copies of the submission(s) 
may be obtained by calling the Treasury Bureau Clearance Officer 
listed. Comments regarding this information collection should be 
addressed to the OMB reviewer listed and to the Treasury Department 
Clearance Officer, Department of the Treasury, Room 11000, 1750 
Pennsylvania Avenue, NW., Washington, DC 20220.

DATES: Written comments should be received on or before April 5, 2010 
to be assured of consideration.

Bureau of Public Debt (BPD)

    OMB Number: 1535-0120.
    Type of Review: Extension of a previously approved collection.
    Title: FHA New Account Request, Transition Request, and Transfer 
Request.
    Form: 5354, 5367, PD F 5366.
    Description: Used to establish account, change information on 
account, and transfer ownership.
    Respondents: Individuals or Households.
    Estimated Total Burden Hours: 50 hours.
    Clearance Officer: Bruce Sharpe (304) 480-8150. Bureau of the 
Public Debt, 200 Third Street, Parkersburg, West Virginia 26106.
    OMB Reviewer: Shagufta Ahmed (202) 395-7873, Office of Management 
and Budget, Room 10235, New Executive Office Building, Washington, DC 
20503.

Celina Elphage,
Treasury PRA Clearance Officer.
[FR Doc. 2010-4626 Filed 3-3-10; 8:45 am]
BILLING CODE 4810-39-P
<PAGE>

                                                                      EXHIBIT 32


                  CERTIFICATIONS PURSUANT TO SECTION 906 OF THE
              SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

     The undersigned, as the President and Chief Executive Officer, and
Executive Vice President and Chief Financial Officer of Exide Technologies,
each certify that

     (1) The accompanying Quarterly Report on Form 10-Q for the period ended
June 30, 2005, fully complies with the requirements of Section 13(a) or 15(d),
as applicable, of the Securities Exchange Act of 1934, as amended; and

     (2) the information contained in the periodic report fairly presents, in
all material respects, the financial condition and results of operations of
Exide Technologies at the dates and for the periods indicated.

     The foregoing certification is made pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) and no purchaser or seller
of securities or any other person shall be entitled to rely upon the foregoing
certification for any other purpose.

     A signed original of this written statement required by Section 906 has
been provided to Exide Technologies and will be retained by Exide Technologies
and furnished to the Securities and Exchange Commission or its staff upon
request.

     The undersigned expressly disclaims any obligation to update the foregoing
certification except as required by law.


Date: November 9, 2005
                                                     /s/ Gordon A. Ulsh
                                           -------------------------------------
                                                      GORDON A. ULSH
                                           PRESIDENT AND CHIEF EXECUTIVE OFFICER



                                                   /s/ J. Timothy Gargaro
                                           -------------------------------------
                                                     J. TIMOTHY GARGARO
                                                EXECUTIVE VICE PRESIDENT AND
                                                  CHIEF FINANCIAL OFFICER
Exhibit 23.3

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in Registration Statement Nos.
333-81208, 333-71954, 333-70976, 333-60132, 333-43038, 333-40322 and 333-35876
on Form S-3 and Nos. 333-70982, 333-38964 and 333-35874 on Form S-8 of our
report dated May 29, 2002, except for Note 6, as to which the date is December
18, 2002, relating to the financial statements of SafeScience Newco, Ltd.,
(which report expresses an unqualified opinion and includes an explanatory
paragraph referring to SafeScience Newco Ltd.'s ability to continue as a going
concern) appearing in this Annual Report on Form 10-K/A of GlycoGenesys, Inc.
for the year ended December 31, 2001.


/s/ Deloitte & Touche LLP

Boston, Massachusetts
December 18, 2002
# C_2015065EN.01001702.xml

| 23.2.2015 | EN | Official Journal of the European Union | C 65/17 |
| --- | --- | --- | --- |

23.2.2015

EN

Official Journal of the European Union

C 65/17

---

Appeal brought on 30 July 2014 by Compagnie des bateaux mouches SA against the judgment of the General Court (Eighth Chamber) delivered on 21 May 2014 in Case T-553/12 Compagnie des bateaux mouches SA v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

(Case C-368/14 P)

(2015/C 065/25)

Language of the case: French

Parties

Parties

Appellant: Compagnie des bateaux mouches SA (represented by: E. Piwnica, lawyer)

Appellant:

Other party to the proceedings: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Other party to the proceedings:

By order of the Court (Sixth Chamber) of 11 December 2014, the Court dismissed the appeal and ordered the Compagnie des bateaux mouches SA to bear its own costs.

---
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Swift Energy
Income  Partners  1986-D,  Ltd.'s  balance  sheet and  statement  of  operations
contained  in its Form 10-Q for the  quarter  ended  September  30,  1997 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-END>                                   SEP-30-1997
<CASH>                                         1,147
<SECURITIES>                                   0
<RECEIVABLES>                                  124,112
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               130,336
<PP&E>                                         12,910,569
<DEPRECIATION>                                 (10,634,167)
<TOTAL-ASSETS>                                 2,406,738
<CURRENT-LIABILITIES>                          55,396
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     2,227,067
<TOTAL-LIABILITY-AND-EQUITY>                   2,406,738
<SALES>                                        350,088
<TOTAL-REVENUES>                               355,267
<CGS>                                          0
<TOTAL-COSTS>                                  263,003<F1>
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                17,664
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            17,664
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   17,664
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1>Includes  lease  operating  expenses,  production  taxes  and  depreciation,
depletion and  amortization  expense.  Excludes general and  administrative  and
interest expense.
</FN>
        

</TABLE>
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2580 Gas-generating device. ( a ) *Identification.* A gas-generating device is a device intended for medical purposes that produces predetermined amounts of selected gases to be used in a closed chamber in order to establish suitable atmospheric conditions for cultivation of microorganisms with special atmospheric requirements. The device aids in the diagnosis of disease.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 54 FR 25046, June 12, 1989; 66 FR 38791, July 25, 2001]